Background: Activation of Toll-like receptors (TLRs) induces inflammatory responses involved in immunity to pathogens and autoimmune pathogenesis, such as in patients with systemic lupus erythematosus (SLE). Although TLRs are differentially expressed across the immune system, a comprehensive analysis of how multiple immune cell subsets respond in a system-wide manner has not been described. Objective: We sought to characterize TLR activation across multiple immune cell subsets and subjects, with the goal of establishing a reference framework against which to compare pathologic processes. Methods: Peripheral whole-blood samples were stimulated with TLR ligands and analyzed by means of mass cytometry simultaneously for surface marker expression, activation states of intracellular signaling proteins, and cytokine production. We developed a novel data visualization tool to provide an integrated view of TLR signaling networks with single-cell resolution. We studied 17 healthy volunteer donors and 8 patients with newly diagnosed and untreated SLE. Results: Our data revealed the diversity of TLR-induced responses within cell types, with TLR ligand specificity. Subsets of natural killer cells and T cells selectively induced nuclear factor k light chain enhancer of activated B cells in response to TLR2 ligands. CD14
hi monocytes exhibited the most polyfunctional cytokine expression patterns, with more than 80 distinct cytokine combinations. Monocytic TLR-induced cytokine patterns were shared among a group of healthy donors, with minimal intraindividual and interindividual variability. Furthermore, autoimmune disease altered baseline cytokine production; newly diagnosed untreated SLE patients shared a distinct monocytic chemokine signature, despite clinical heterogeneity. Conclusion: Mass cytometry defined a systems-level reference framework for human TLR activation, which can be applied to study perturbations in patients with inflammatory diseases, such as SLE. (J Allergy Clin Immunol 2015;nnn:nnn-nnn.)
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Pattern recognition receptors (PRRs) recognize conserved features of foreign microorganisms during infection and self-molecules in tissue injury. 1, 2 Toll-like receptors (TLRs) were the first identified family of PRRs; the human genome encodes 10 TLRs. 3, 4 TLRs are type 1 transmembrane receptors with an extracellular ligand-binding domain, a transmembrane domain, and a cytoplasmic Toll/IL-1 receptor (TIR) domain. 3, 5 TLRs are expressed on the plasma membrane (TLR1, TLR2, and TLR4-TLR6) or in endosomes (TLR3 and TLR7-TLR9). 6 Ligand binding to TLRs induces dimerization of the TIR domains. This dimer functions as a scaffold for myeloid differentiation primary response gene 88 (MyD88) or TIR domain-containing adaptor inducing IFN-b (TRIF) protein adaptor complexes, which then activate mitogen-activated protein kinase and nuclear factor k light chain enhancer of activated B cells (NF-kB) pathways or interferon regulatory factors, respectively. 7, 8 Crosstalk with other pathways elicits the production of inflammatory and regulatory cytokines that shape adaptive immunity. 9 Although TLR-induced inflammation is important for antimicrobial responses, inappropriate TLR recognition of self-molecules results in development of autoimmune diseases, such as systemic lupus erythematosus (SLE). 10, 11 In patients with SLE, self-nucleic acid-containing antibodies form immune complexes that can sequentially activate Fcg and endosomal TLR receptors. [12] [13] [14] TLR signaling and cytokine production are precisely regulated at multiple levels to maintain the balance between protective immunity and inflammatory disease. First, the cellular compartmentalization of TLRs limits their accessibility to ligands. Second, different immune cell populations selectively express certain TLRs and TLR-inducible signaling pathways. 15 Finally, each immune cell subset produces a distinct set of cytokines. Systems-scale proteomic approaches have previously been applied to characterize this level of complexity of TLR networks. For example, mass spectrometry-based phosphoproteomic analysis was used to profile TLR-induced signaling in murine macrophages. 16, 17 A separate study applied mass spectrometry-based secretomic analysis to evaluate cytokine production elicited by TLR activation in murine macrophages and dendritic cells. 18, 19 Although informative, these studies have provided global views of TLR signaling and cytokine production in specific immune cell subsets but not within the context of an integrated cellular immune system with single-cell resolution. To achieve a systems-level perspective of TLR biology that simultaneously accounts for functional diversity at the single-cell level, the activation of intracellular signaling pathways, and cytokine production, we capitalized on the ability of mass cytometry to capture this complexity. Here, 40-parameter mass cytometry was used to define a reference framework for human TLR activation ex vivo in whole blood samples. The application of this framework to evaluate cytokine alterations in a systemic inflammatory disease, such as SLE, revealed a characteristic abnormal monocytic chemokine signature in patients with SLE in the basal state in the absence of any ex vivo stimulation. This study demonstrates the utility of this approach to characterize TLR activation across the immune system and in patients with inflammatory diseases in general.
METHODS

Study participants
All human donors were enrolled under a study protocol approved by the Institutional Review Board of the Research Compliance Office at Stanford University. Written informed consent was obtained from all study participants. Inclusion/exclusion criteria for healthy volunteer donors and patients with SLE can be found in the Methods section and Table E1 in this article's Online Repository at www.jacionline.org. Patients with SLE fulfilled the revised American College of Rheumatology diagnostic criteria (see Table E2 in this article's Online Repository at www.jacionline.org). 20 Sample processing, stimulation, and cytometric analysis Donor whole blood was collected in heparinized vacutainers (BD, Franklin Lakes, NJ), incubated at 378C with TLR ligands 21 (see Table E3 in this article's Online Repository at www.jacionline.org), fixed, and permeabilized for intracellular staining. Conditions for signaling proteins and intracellular cytokine staining were adapted from previous studies (see the Methods section in this article's Online Repository). 22, 23 Clone, vendor, and conjugation information for all mAbs are shown in Table E4 in this article's Online Repository at www.jacionline.org. Cells were analyzed on a CyTOF instrument (Fluidigm, South San Francisco, Calif). Data were acquired by using internal metal isotope bead standards, normalized, and analyzed as previously described (FlowJo software; TreeStar, Ashland, Ore and Cytobank, Mountain View, Calif). 24, 25 ''Signaling network heatmap'' visualization tool 
CD14
hi monocytes combinatorial cytokine heatmap
In brief, cytokine positivity was determined in a binary fashion based on the 95th percentile intensity threshold; CD14 hi monocyte subpopulations expressing different cytokine combinations were clustered based on similar cytokine response profiles induced by TLR ligands. See the Methods section in this article's Online Repository for data processing and computational design.
Statistical analysis of CD14 hi monocyte cytokine signatures
Comparison of the mean percent positivity (defined by the 95th percentile threshold as above) for each monocytic cytokine between the SLE and healthy control groups was performed by applying a Student t test with Bonferroni adjustment, which apportions the significance level evenly among the 9 hypothesis tests (P 5 .0056, adjusted significance level; Microsoft Excel 2011).
RESULTS
Mass cytometry identifies major immune cell subsets in human whole blood By using a priori knowledge about hematopoietic lineages, human blood cells were categorized into 11 major immune cell subsets (Fig 1 and 28 and FcεRI and CD123 coexpression identified basophils. 31 TLRs, their ligands, signaling pathways, and cytokines examined are listed in Fig 1. 
A signaling network heatmap visualization tool provides an integrated view of TLR signaling patterns
Changes in the activation states of 9 signaling proteins were monitored in 11 cell subsets in response to 8 stimuli.
Conventional depiction of such high-density data with 2-dimensional plots, histograms, or heatmaps does not capture an integrated view of all the measured parameters nor does it make the most of the single-cell resolution. A signaling network heatmap visualization tool was developed to overcome this analytic challenge. In brief, up to 1000 representative single cells were sampled from each immune cell subset and TLR stimulus condition. For each cell type and condition, cells were ordered by expression value for every signaling protein indexed from lowest to highest arcsinh transformed value. The arcsinh scale, a bioexponential transformation used with flow cytometric data, was chosen over a traditional log scale to account for negative values. 32 For each cell type and signaling protein, expression values for that signaling protein in the stimulated and unstimulated conditions were paired according to their indexed transformed value. Differences between these paired values Table E4 ), and analyzed by means of mass cytometry. Representative data from 1 healthy donor are shown. ODN, Oligodeoxynucleotide; pERK, phosphorylated extracellular signal-regulated kinase; pHH3, phosphorylated histone H3; pTBK1, phosphorylated TANK-binding kinase 1. resulted in single-cell signaling fold changes (Fig 2, A) , which were colored according to the arcsinh difference (Fig 2, B) and arranged into a signaling node (Fig 2, C) based on their original index position. These signaling nodes were then arranged into pathways downstream of MyD88 and TRIF adaptor protein complexes (Fig 2, D) hi monocytes express both TLR2 and dectin-1 receptors. 33 Like CD1c 1 DCs, granulocytes responded to all extracellular ligands and R848 (Fig 2, E) . In contrast, only a fraction of basophils responded to PAM2 (TLR2/6 ligand; 15.5% responders) and LPS (TLR4 ligand; 7.2% responders) with induction of IkBa degradation and p38 phosphorylation (Fig 2, E) . This restricted basophil-signaling profile is concordant with previous studies on the roles of TLR2-and TLR4-mediated basophil activation in augmenting allergic reactions. 34 In the lymphoid lineage endosomal TLR agonists induced NF-kB and cAMP response element-binding protein (CREB) pathways in B cells (Fig 3, A , and see Fig E4 in this article's Online Repository at www.jacionline.org). Unexpectedly, the TLR2 ligands PAM2 (TLR2/6) and PAM3 (TLR1/2) selectively activated the NF-kB pathway in NK and T-cell subsets (Fig 3,  B and C) . In approximately one third of CD56 hi NK cells, IkBa (Fig 3, B) and T cells (Fig 3, C) Fig E5, A) . These responses were far less apparent in CD16
hi NK cells (Fig 3, B , and see Fig E5, B) . PAM2 and PAM3 stimulations were performed in 10 additional donor blood samples, resulting in IkBa degradation in 36% (SD, 12.67%) and 24.3% (SD, 17%) of CD56 hi NK cells, respectively (see Fig E5, B) , to assess the reproducibility of this observation. NK cells were enriched to approximately 96.75% purity (see the Methods section in this article's Online Repository) and stimulated with PAM2 and PAM3 to understand this further. IkBa degradation was mainly observed in the CD56 hi NK population in response to PAM2, suggesting that this TLR ligand directly activated these cells (see Fig E6 in this article' s Online Repository at www.jacionline.org).
As observed for NK cells, PAM2 and PAM3 stimulation also activated the NF-kB pathway in CD4 T cells (Fig 3, C) . This activity was even less apparent in CD8 T cells (Fig 3, C , and see Fig E7, A, in this article's Online Repository at www.jacionline.org). In a group of 10 additional donors, an average of 14.5% (SD, 5.1%) and 11.9% (SD, 7.8%) CD4 T cells responded to PAM2 and PAM3, respectively (see Fig E7, B) . To investigate whether PAM2 and PAM3 directly activated T cells, T cells enriched to approximately 96% purity were stimulated with these ligands, and exclusive NF-kB pathway induction was observed in similar percentages of cells (average of 14.03% and SD of 5.1% for PAM2 and average of 4.32% and SD of 5.1% for PAM3; see Fig E7, C) , indicating that these lipopeptides are acting directly on T lymphocytes. Although previous studies have explored the role of TLR2 agonists in T-cell activation, 35, 36 activation of specific signaling pathways has not been well defined.
TLR-induced cytokine signatures demonstrate cell type and TLR ligand specificity
Production of 16 cytokines downstream of the signaling pathways examined above was simultaneously measured in myeloid and lymphoid cell types (Fig 1) . Cytokine data were analyzed by using a Boolean gating strategy, with positivity defined in Fig E8 in this article' s Online Repository at www.jacionline.org. TLR stimulation induced the production of 10 of 16 cytokines in 1 or more myeloid cell populations, with minimal cytokine production in lymphoid cells (Fig 4 and Mirroring TLR-induced signaling patterns, CD14 hi monocyte and CD1c
1 DC cytokine response profiles also largely overlapped (Fig 4 and Fig E10) . LPS and R848 induced different chemokine responses in CD14 hi monocytes, and LPS elicited IL-8 production in the absence of monocyte chemotactic protein 1 (MCP-1) expression, whereas R848 induced the converse (Fig 4) . CD16 hi monocytes were not included in the cytokine analysis because after the 6-hour stimulation period, CD16 was shed from nonclassical monocytes.
Unlike monocytes and CD1c 1 DCs, pDCs demonstrated a restricted cytokine response repertoire, primarily IFN-a production in response to endosomal TLR agonists (Fig 4) . Granulocytes and basophils produced macrophage inflammatory protein 1b (MIP-1b), IL-8, and IL-1 receptor antagonist only (see Fig E9, A) . Minimal cytokine production was observed in the lymphoid compartment (see Fig E9, B) , even for B cells, in which endosomal TLR stimulation induced signaling responses (Fig 3,  A) . Despite the PAM2-and PAM3-driven NF-kB signaling activation observed in NK and T-cell subpopulations (Fig 3, B and C), cytokine responses were not induced in these cells (see Fig E9, B) , suggesting that these TLR ligands play a costimulatory role in antigen receptor activation.
TLR ligands induce diverse combinatorial cytokine signatures in CD14 hi monocytes
Combinatorial cytokine production is the ability to produce numerous combinations of cytokines simultaneously. T cells have been shown to exhibit combinatorial polyfunctional cytokine responses that are correlated with resistance to disease. 37 ,38 However, it is not clear whether myeloid cell populations share this capability. In this study CD14 hi monocytes produced the most diverse cytokine responses to TLR stimulation (Fig 4 and  see Fig E10) . Only subsets with a minimum 1% population frequency were included in the analysis to emphasize salient polyfunctional combinations. Here we found that 83 of the possible 512 combinations meet that threshold (Fig 5) . Hierarchic clustering of these cytokines into a combinatorial heatmap exposed relationships between coexpressed cytokines (Fig 5,  left panel) and between TLR stimuli that elicit similar cytokine responses (Fig 5, right panel) . IL-1b and MIP-1b behaved the most similarly, and the proinflammatory cytokines IL-12 and TNF-a formed a separate cluster.
PAM2, PAM3, and flagellin elicited similar cytokine profiles; generally, 2 or 3 cytokines were expressed, primarily IL-1b, MIP-1b, and IL-8 (Fig 5, right panel) . LPS and zymosan also induced similar combinatorial cytokine signatures, likely related to the synergistic effects of dectin-1 with TLR2 and TLR4.
33
R848 and LPS induced comparable monocytic polyfunctionality (Fig 5, right panel) but differed in the type of cytokines induced (Fig 5, left panel) . These cytokine combinatorial phenotypes suggest a monocytic functional specialization that cannot be defined by surface marker-based classifications alone.
CD14
hi monocytes from patients with SLE show an inflammatory cytokine signature typified by MCP-1
Intraindividual and interindividual variabilities in healthy donors were determined to assess the reproducibility of this approach for evaluating TLR-induced cytokine production. Monocytic TLR-induced cytokine patterns were highly conserved over time for a single donor (Fig 6, A) and among 9 healthy donors (Fig 6, B) . The least degree of intraindividual and interindividual variability was observed for MIP-1b production, with the SD ranging from 1.02% (LPS) to 5.25% (R848) for 1 donor over time and 0.41% (R848) to 4.44% (LPS) among 9 donors (see Fig E11 in this article' s Online Repository at www.jacionline.org). IL-12 production varied most, with an SD of 13.3% for 1 donor longitudinally and 18.2% for 9 donors in the R848 condition (see Fig E11) . These results demonstrate the reproducibility of this experimental platform and validate the data as a reference framework of TLR-induced cytokine profiles in healthy donors. This reference framework was used to compare cytokine profiles in patients with an inflammatory disease in which abnormal TLR responses drive pathologic cytokine production, such as SLE. 39, 40 Analysis of blood samples from 8 patients with newly diagnosed, untreated, and clinically heterogeneous SLE (see Table E2 ) revealed a common abnormal CD14 hi monocytic cytokine signature in the basal state in the absence of ex vivo stimulation (Fig 7) . Ninety-fifth percentile baseline thresholds (see Fig E7) for all cytokines were defined based on an initial time point when blood was immediately processed after draw (time zero, see Fig E10) to internally control these experiments. CD14
hi monocytes from each of the 8 patients with newly diagnosed and untreated SLE exhibited increased MCP-1 levels (average, 82.6%; SD, 9.7%; see Fig E8) after 6 hours of secretion block in the absence of any stimulation. Under these conditions, MCP-1 levels in corresponding healthy control subjects (different healthy donors than those in Fig 6) proinflammatory chemokine involved in the immunopathogenesis of human and murine lupus nephritis. 41 In murine SLE models MCP-1 inhibition ameliorates lupus nephritis. 42 Previous studies and our data indicate that MCP-1 holds promise as a therapeutic target. [42] [43] [44] [45] Levels of other cytokines, such as MIP-1b and TNF-a, were also increased in samples from patients with newly diagnosed and untreated SLE compared with those in healthy donor samples (Fig 7 and see Fig E13 in this article's Online Repository at www.jacionline.org). Bonferroni-adjusted t test calculation comparing the average expression of each cytokine between the SLE and healthy control groups confirmed statistically significant differences in MCP-1 (P 5 7.6E 210 ), MIP-1b (P 5 .002), and TNF-a (P 5 .001) levels. Comparison of cytokine profiles for all 11 cell subsets (as in Fig 1) for all 8 SLE versus healthy matched control pairs did not demonstrate any statistically significant differences other than those observed in CD14 hi monocytes (data not shown). Although all samples from patients with SLE demonstrated this common monocytic cytokine signature (MCP-1, MIP-1b, and TNF-a) based on single cytokine positivity (Fig 7) , patients' combinatorial cytokine profiles differed (see Fig  E14 in this article's Online Repository at www.jacionline.org).
In this study, using a systems-scale single-cell proteomic approach to characterize human TLR signaling and cytokine networks, we defined a reference framework that can be applied to study alterations in these parameters in patients with inflammatory disease.
DISCUSSION
TLRs (and other PRRs) are involved in the complex balance between protective immunity and inflammatory disease. To elucidate how TLR networks calibrate innate and adaptive immune responses to maintain this balance, we have used high-dimensional mass cytometry to broadly measure intracellular signaling responses and cytokine profiles in healthy subjects and patients with newly diagnosed and untreated SLE.
This comprehensive TLR activation analysis in healthy subjects corroborates previous findings in TLR biology and reveals novel TLR signaling responses in NK and T cells. A signaling network heatmap visualization tool (Fig 2, A-D) was developed to depict these TLR-induced signaling patterns with single-cell resolution. This method enables display of the activation characteristics of 9 signaling proteins in 11 cell subsets in response to 8 TLR ligands, with more than 600 features and approximately 2 million data points in Fig 2, E. This is a scalable tool to visualize high-dimensional data sets that provides a framework through which the signaling biology of entire receptor systems can be explored with nearly single-cell resolution.
Although TLR responses have been extensively investigated in myeloid cells, they are not well defined in the lymphoid lineage, with the exception of B cells. 46 In our analysis only TLR2 and TLR5 ligands activated signaling, primarily in CD56 hi NK cells (Fig 3, B) . TLR2-dependent NK cell activation has been linked to poxvirus and mycobacterial immunity. 47, 48 Notably, TLR2-mediated mycobacterial recognition promotes NK cell-DC cross-talk and IL-12 production, 49 but it is unclear whether TLR2 stimuli directly activated NK cells. It is unlikely that the observed signaling responses (Figs 2, E, and 3) were indirect (paracrine) in nature, given a 30-minute incubation; however, indirect effects cannot be completely excluded. Therefore purified cell populations were assayed to evaluate noncanonical TLR ligand responses in NK cells and T cells. Here we found that an enriched NK cell population responded to TLR2 ligands within 30 minutes, showing that NK cells can directly respond to these ligands (see Fig E6) . hi monocytes from patients with SLE show an inflammatory chemokine signature typified by MCP-1. Cytokine positivity was defined based on the 95th percentile threshold of blood processed immediately after draw (time zero) and thus were internally controlled. Each radar plot represents the CD14 hi monocytic cytokine signature of a patient with SLE (red line) versus a healthy sex-matched control subject (blue line) after a 6-hour incubation period with protein secretion inhibitor (no exogenous stimuli).
Similarly, TLR responses in T cells are also poorly described. A subset of CD4 T cells degraded IkBa after TLR2 stimulation (Fig 3, C) , but this did not lead to cytokine production (see Fig E9,  B) . This pathway selectivity and the inability of TLR2 ligands alone to induce cytokine production in T cells suggest a costimulatory role for TLR2 in T-cell activation. This observation is consistent with and might provide a molecular mechanism for previous reports that mycobacterial ligands and the live BCG vaccine enhance T-cell proliferation and cytokine production only when coupled with T-cell receptor engagement. 36, 50 These results also suggest that microbial lipopeptides should be explored as adjuvants in vaccine design. Detailed NK cell and T-cell phenotyping could be incorporated in future studies to further understand this isolated signaling response to TLR2 ligands.
TLR activation was tracked from signal transduction to cytokine production, demonstrating how different TLR agonists elicited distinct cytokine combinations across the immune system. To construct a systems-level TLR activation reference framework, we compared TLR-induced cytokine responses longitudinally in a single donor and among healthy donors. Minimal intraindividual and interindividual variability (Fig 6) suggested the applicability of this framework to study an inflammatory disease, such as SLE. Compared with monocytes from healthy control subjects, CD14
hi monocytes from 8 patients with newly diagnosed and untreated SLE exhibited a statistically significant distinct cytokine signature (MCP-1, MIP-1b, and TNF-a) at the basal state, with the most prominent and uniform of the cytokines being MCP-1 (Fig 7 and see Fig E13) . These 8 patients with SLE manifested diverse clinical symptoms (see Table E2 ), which is characteristic of this complex autoimmune disorder. Yet, significantly, by using our analysis system, they all expressed this cytokine signature, particularly MCP-1, suggesting that they shared an underlying basis that could be useful in both diagnosis and treatment. Additionally, these patient samples were obtained before any immunomodulatory treatment, and thus there was no heterogeneity introduced by drug treatments.
MCP-1 (also known as CCL2) recruits monocytes and lymphocytes to sites of inflammation. 45 Increased MCP-1 levels have been detected in patients with a variety of autoimmune disorders [51] [52] [53] and often correlate with disease activity. 43, 45, 54 MCP-1 might play a critical role in autoimmune end-organ damage, and MCP-1 neutralization has been shown to ameliorate disease in rodent models of SLE. 42 The mechanism responsible for increased MCP-1 production in patients with SLE is unclear, but available data suggest several possibilities.
First, MCP-1 is a known type I interferon inducible chemokine. 55 Multiple transcriptomic studies have observed an IFN-a signature in patients with SLE, likely induced by nucleic acid-containing immune complexes activating endosomal TLRs in pDCs 12, 56 and possibly leading to MCP-1 induction. Second, Fcg receptor activation elicits monocytic MCP-1 production, 57 and thus circulating immune complexes in patients with SLE could explain MCP-1 induction. 14 Finally, although RNA-containing immune complexes in patients with SLE might activate TLR8 in monocytes, leading to MCP-1 production, monocytic cytokine profiles from patients with SLE did not match R848-induced cytokine profiles, making this explanation unlikely. Regardless of the cause of MCP-1 production, MCP-1 neutralization could potentially serve as an anti-inflammatory adjunctive therapy to reduce the use or dosage of cytotoxic immunosuppressive drug regimens that are necessary to control SLE.
In conclusion, mass cytometry was used to generate a comprehensive reference framework of human TLR-driven immune responses in myeloid and lymphoid lineages. Analysis of samples from patients with SLE demonstrated that this reference framework could be applied to study inflammatory disease. Additionally, this study establishes a paradigm for using high-dimensional single-cell proteomic approaches to generate reference maps of other receptor systems.
